您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (3): 94-99.doi: 10.6040/j.issn.1671-7554.0.2016.162

• 临床医学 • 上一篇    下一篇

Keap1在肾细胞癌中的表达及其作用

史培堃1,曾贝妮1,吴伟芳1,胡晓燕1,马天加2,周亚滨1   

  1. 1.山东大学医学院病原生物学系, 山东 济南 250012;2.山东大学第二医院泌尿外科, 山东 济南 250033
  • 收稿日期:2016-02-22 出版日期:2017-03-10 发布日期:2017-03-10
  • 通讯作者: 周亚滨. E-mail:zyb@sdu.edu.cn; 马天加. E-mail:sdmttjj@sina.com E-mail:zyb@sdu.edu.cn; sdmttjj@sina.com
  • 基金资助:
    山东省重点研发项目(2015GSF118147);山东省自然科学基金(ZR2011HL010)

Expression and role of Keap1 in renal cell carcinoma

SHI Peikun1, ZENG Beini1, WU Weifang1, HU Xiaoyan1, MA Tianjia2, ZHOU Yabin1   

  1. 1. Department of Pathogenic Biology, School of Medicine, Shandong University, Jinan 250012, Shandong, China;
    2. Department of Urology, Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Received:2016-02-22 Online:2017-03-10 Published:2017-03-10

摘要： 目的 探讨Kelch样ECH相关蛋白-1(Keap1)在肾癌中的表达及其在肾癌发生发展中的作用。 方法 采用Q-PCR技术检测32例肾癌患者的肿瘤组织和肾癌旁组织中Keap1、核因子E2相关因子2(NFE2L2)的表达;免疫组织化学染色法检测上述肾癌患者肿瘤组织和肾癌旁组织中Keap1、NFE2L2的表达;CCK-8法检测和克隆形成法检测过表达Keap1后对肾癌细胞系ACHN增殖活性以及克隆形成能力的影响。 结果 实时荧光定量PCR(Q-PCR)结果显示,75.00%患者Keap1 mRNA的表达癌旁组织高于肿瘤组织(P=0.000),62.50%患者NFE2L2 mRNA的表达肿瘤组织高于癌旁组织(P=0.046)。免疫组化结果显示32例肾癌患者中,Keap1蛋白在癌旁组织(87.50%)的表达高于肿瘤组织(25.00%)(P=0.000),NFE2L2蛋白在肿瘤组织(81.25%)的表达高于癌旁组织(46.88%)(P=0.004)。高表达Keap1后,NFE2L2的表达降低,肾癌细胞系ACHN的增殖能力和克隆形成能力降低。 结论 Keap1/NFE2L2通路在肾癌的发生和发展中可能发挥重要作用,Keap1的表达对肾癌可能起到抑制作用。

关键词: 肾细胞癌, 细胞增殖, 核因子E2相关因子2, Kelch样ECH相关蛋白-1

Abstract: Objective To investigate the expression of Keap1 and evaluate its role in renal carcinoma. Methods The total RNA of tumor tissues and adjacent tissues were isolated from 32 cases of renal carcinoma treated during May 2014 to April 2015 by TRIzol. The expressions of Keap1 and NFE2L2 were detected by Q-PCR technology and immunohistochemical staining. The changes of proliferation and colony forming ability of ACHN after overexpressed Keap1 were detected by CCK-8 cell proliferation and clone formation assay. Results Q-PCR results showed that the expression of Keap1 mRNA in adjacent tissues in 75% patients was higher than that in tumor tissues(P=0.000), the expression of NFE2L2 mRNA in tumor tissues in 62% patients was higher than that in adjacent tissues(P=0.046). The immunohistochemical results showed that the expression of Keap1 protein in adjacent tissues(87.50%)was higher than that in tumor tissues(25.00%)(P=0.000), and the expression of NFE2L2 protein in tumor tissues(81.25%)was higher than that in adjacent tissues(46.88%)(P=0.004). Overexpression of Keap1 decreased proliferation and colony forming ability of renal cell carcinoma cell line ACHN. Conclusion The abnormal expression of Keap1 in tumor tissues indicates that the Keap1-NFE2L2 pathway may play an important role in renal carcinoma. Keap1 has a probable inhibiting effect on the progression of renal carcinoma.

Key words: Renal carcinoma, Kelch-like ECH-associated protein1, Proliferation, Nuclear factor E2-related factor 2

中图分类号: 

  • R574
[1] Brookman-May SD, May M, Shariat SF, et al. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma-results from a comprehensive multi-centre database(CORONA/SATURN-Project)[J]. BJU Int, 2013, 112(7): 909-916.
[2] Huang Y, Li W, Su ZY, et al. The complexity of the Nrf2 pathway: beyond the antioxidant response[J]. J Nutr Biochem, 2015, 26(12): 1401-1413.
[3] OConnell MA, Hayes JD. The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic[J]. Biochem Soc Trans, 2015, 43(4): 687-689.
[4] Leinonen HM, Kansanen E, Polonen P, et al. Role of the Keap1-Nrf2 pathway in cancer[J]. Adv Cancer Res, 2014, 122: 281-320. doi: 10.1016/B978-0-12-420117-0.00008-6.
[5] Leinonen HM, Kansanen E, Polonen P, et al. Dysregulation of the Keap1-Nrf2 pathway in cancer[J]. Biochem Soc Trans, 2015, 43(4): 645-649.
[6] Kobayashi A, Kang MI, Okawa H, et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2[J]. Mol Cell Biol, 2004, 24(16): 7130-7139.
[7] Guo Y, Yu S, Zhang C, et al. Epigenetic regulation of Keap1-Nrf2 signaling[J]. Free RadicBiol Med, 2015, 88(Pt B): 337-349.
[8] Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity[J]. J Biol Chem, 1991, 266(18): 11632-11639.
[9] Tian H, Zhang B, Di J, et al. Keap1: One stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL[J]. Cancer Letters, 2012, 325(1): 26-34.
[10] Zhao CR, Gao ZH, Qu XJ. Nrf2-ARE signaling pathway and natural products for cancer chemoprevention[J]. Cancer Epidemiol, 2010, 34(5): 523-533.
[11] Padmanabhan B, Tong KI, Ohta T, et al. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer[J]. Mol Cell, 2006, 21(5): 689-700.
[12] Wang R, An J, Ji F, et al. Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues[J]. Biochem Biophys Res Commun, 2008, 373(1): 151-154.
[13] 曹宝山, 朱翔, 陈森, 等. Keap1在非小细胞肺癌中的表达及与化疗疗效相关性的研究[J]. 中国肺癌杂志, 2012, 15(10): 591-596. CAO Baoshan, ZHU Xiang, CHEN Sen, et al. Keap1 expression for predicting the chemoresistance and prognosis of advanced non-small cell lung cancer[J]. Chinese Journal of Lung Cancer, 2012, 15(10): 591-596.
[14] 张凯茹, 闫惠琴, 王燕, 等. Nrf2及其靶基因在人肺腺癌A549顺铂耐药细胞株中的表达和意义[J]. 中国肺癌杂志, 2009, 12(11): 1150-1154. ZHANG Kairu, YAN Huiqin, WANG Yan, et al. Expression and significance of Nrf2 and its target genes in pulmonary adenocarcinoma A549 cells resistant to cisplatin[J]. Chinese Journal of Lung Cancer, 2009, 12(11): 1150-1154.
[15] Ohta T, Iijima K, Miyamoto M, et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth[J]. Cancer Res, 2008, 68(5): 1303-1309.
[16] Shim GS, Manandhar S, Shin DH, et al. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway[J]. Free RadicBiol Med, 2009, 47(11): 1619-1631.
[17] Huang CF, Zhang L, Ma SR, et al. Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma[J]. PLoS One, 2013, 8(12): e83479. doi: 10.1371/journal.pone.0083479. eCollection 2013.
[1] 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7-14.
[2] 马青源,蒲沛东,韩飞,王超,朱洲均,王维山,史晨辉. miR-27b-3p调控SMAD1对骨肉瘤细胞增殖、迁移和侵袭作用的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 32-37.
[3] 刘振中, 姜笃银, 王魏, 宗宪磊, 张基勋, 刘磊. 转化生长因子-β1噬菌体模拟肽促进成纤维细胞增殖的效果[J]. 山东大学学报（医学版）, 2015, 53(3): 50-55.
[4] 涂燕, 李振江, 汤爱平, 费妍, 李慧慧, 李剑, 贺文凤. 干扰CD147表达抑制白血病细胞SHI-1增殖及移行[J]. 山东大学学报（医学版）, 2014, 52(9): 1-5.
[5] 赵龙, 关广聚. 十字花科蔬菜摄入量与肾细胞癌罹患风险的Meta分析[J]. 山东大学学报（医学版）, 2014, 52(7): 82-89.
[6] 赵华1，徐洋洋2，鹿向东3，徐同江1 . Ki-67、PTTG、VEGF与垂体瘤卒中的相关性[J]. 山东大学学报（医学版）, 2014, 52(5): 82-85.
[7] 徐敏，庄向华，孙爱丽，倪一虹，孙福敦，陈诗鸿. 高糖对RSC96雪旺细胞的损伤机制[J]. 山东大学学报（医学版）, 2014, 52(5): 44-48.
[8] 王亚云1, 王一彪1, 张雪1, 林梅1, 苏宏1，马宇1，朱晓波1, 陈欧2. PS-341对肺动脉高压大鼠Nrf2/NF-κB表达的影响及作用机制[J]. 山东大学学报（医学版）, 2014, 52(2): 6-11.
[9] 来成军1,2， 曲红华3，郭晓宇4， 郭兆新2，邢召全2，周尊林2，徐忠华2，刘照旭2,5. 二甲双胍对肾癌786-O细胞迁移和侵袭的影响[J]. 山东大学学报（医学版）, 2014, 52(2): 29-32.
[10] 周静, 郑亚冰, 闫莉, 常晓天, 赵珊, 荣风年. 雌激素及顺铂对卵巢癌细胞A2780PADI4的表达及其细胞增殖的影响[J]. 山东大学学报（医学版）, 2014, 52(12): 30-34.
[11] 陈洪忠, 李海珍, 任冬梅. 木犀草素对EA.hy926细胞Nrf2信号通路的激活作用及H2O2致氧化损伤的保护作用[J]. 山东大学学报（医学版）, 2014, 52(11): 6-10.
[12] 王晓蕾1,郏雁飞2,郑燕2,刘华2,汪运山2. STAT3真核表达质粒的构建及对胃癌细胞增殖的影响[J]. 山东大学学报(医学版), 2013, 51(9): 45-49.
[13] 李亚男1，蒋玲1，胡秀慧1，张晓黎1，李杰2. 碘酸钾和双酚A对甲状腺乳头状癌细胞增殖的影响[J]. 山东大学学报(医学版), 2013, 51(3): 52-57.
[14] 陈源红1，曾怡1，罗艳红2. 溪黄草对肝癌细胞HepG2增殖及凋亡的影响[J]. 山东大学学报(医学版), 2013, 51(11): 42-45.
[15] 戴新1,郑燕2，郏雁飞2，肖东杰2，童书青1，汪运山2. EC1基因真核表达质粒的构建及对胃癌细胞增殖的影响[J]. 山东大学学报(医学版), 2012, 50(6): 75-.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发